AI Radiology ROI Calculator: What Hospitals Actually Measure in Year One

Why Year-One AI Radiology ROI Is Harder to Measure Than Vendors Claim

Most AI radiology vendors quote turnaround time. A few mention radiologist throughput. Almost none address the three measurement tracks that actually determine whether the board renews the contract: missed-finding liability exposure, downstream cost avoidance from earlier diagnosis, and equipment utilisation efficiency. Without baseline data for all five tracks captured before go-live, a hospital cannot produce a credible year-one ROI figure—and cannot negotiate from strength at contract renewal.

Fractify was designed with measurement in mind. Every DICOM study processed by the platform generates a structured audit log: study UID, processing timestamp, flagged findings with urgency score, Grad-CAM heatmap coordinates, and final radiologist disposition. That log is the raw material for ROI calculation. Hospitals that integrate Fractify's audit data with their billing system and incident registers typically have enough data for a defensible CFO-ready ROI report within six months of go-live.

The Five Measurement Tracks Every Hospital CFO Should Track

Track 1: Report Turnaround Time

TAT is the most visible metric and the easiest to measure. Define it consistently—most hospitals use "DICOM received" to "report signed"—and measure it at the 50th and 95th percentile, not just the mean. Averages hide backlogs. Fractify's urgency scoring system, which classifies studies on a 1–5 scale, changes how work is queued. Tension Pneumothorax and Aortic Dissection cases automatically receive urgency score 5 and surface at the top of the reading queue regardless of arrival order. In hospitals with mixed-modality reading rooms, this alone shrinks critical-finding TAT by 40–60% in the first quarter.

Benchmark targets for year one: emergency CT TAT below 20 minutes for urgency-5 studies; routine chest X-ray TAT under 4 hours. Document your pre-deployment averages with three months of PACS timestamps before go-live.

Track 2: Missed-Finding Rate

This is the metric that matters most to risk managers and the one vendors are most reluctant to discuss. Missed findings result in re-read requests, amendment reports, patient callbacks, and in serious cases, legal exposure. Fractify's detection models cover 18+ pathology categories in chest X-ray alone, including Pneumonia, Pleural Effusion, Cardiomegaly, and Pneumothorax. In brain MRI, Fractify achieves 97.9% tumour detection accuracy; in skeletal imaging, 97.7% fracture detection accuracy across long bones, wrist, and spine.

Measuring missed-finding rate requires cross-referencing AI flags against final radiologist reports and tracking amendment rate per 1,000 studies. A hospital processing 50,000 studies per year that reduces amendment rate by 2 per 1,000 prevents 100 amended reports annually—each carrying administrative cost and potential liability.

Track 3: Radiologist Throughput

AI does not replace radiologists; it restructures how they allocate attention. Fractify's prior-study comparison feature automatically overlays the current scan against historical PACS images, flagging interval changes. A radiologist reviewing a follow-up CT lung nodule study no longer needs to manually pull the prior scan—Fractify pre-loads the comparison with change delta highlighted. This alone reduces per-study cognitive load and allows experienced radiologists to review 15–25% more studies per shift without increasing error rates.

Track throughput as studies reviewed per radiologist per shift, stratified by modality. Most hospitals see throughput gains in the first 60 days simply from the AI pre-read sorting the work queue by urgency.

Track 4: Equipment Utilisation Efficiency

AI radiology reduces the scan volume required to reach a diagnosis. When Fractify flags an Intracranial Hemorrhage on a non-contrast CT—covering all 6 subtypes including Epidural, Subdural, Subarachnoid, Intraparenchymal, Intraventricular, and Mixed—the clinical team has a structured, image-annotated finding to act on immediately. Without AI, equivocal initial reads often trigger a repeat scan or an additional MRI "for clarification." Eliminating unnecessary confirmatory scans reduces scanner hours and contrast usage.

Measure this as confirmatory-scan rate per initial study, broken down by modality. Even a 5% reduction in repeat-scan orders on a 300-scan-per-day department frees substantial scanner time annually.

Track 5: Downstream Cost Avoidance from Earlier Diagnosis

The hardest metric to quantify but the highest value: earlier diagnosis leads to earlier treatment, which reduces episode cost. A missed Stage II lung nodule that becomes a Stage III diagnosis 18 months later represents a cost differential that dwarfs the annual software licence fee. Fractify's chest X-ray module flags pulmonary nodules for follow-up with specific size and morphology data, feeding into structured HL7/FHIR messages that trigger follow-up scheduling workflows in the hospital information system.

Benchmarking Data: AI Radiology Before vs After Deployment

Fractify's Validated Performance Metrics and Their Direct ROI Linkage

Building Your ROI Business Case: A Five-Step Framework

Fractify, developed by Databoost Sdn Bhd, was engineered for hospital deployment environments that demand audit trails. The platform integrates with PACS via DICOM, with clinical information systems via HL7/FHIR, and with role-based access control (RBAC) systems for compliance reporting. This integration architecture is what makes the five-track ROI framework executable rather than theoretical.

According to the WHO's global radiology workforce guidelines, hospitals in Asia face radiologist shortages that make AI augmentation financially necessary, not merely beneficial. A peer-reviewed analysis in European Radiology confirmed that AI-assisted radiology in high-volume settings reduces per-study reading time by a median of 22%, with the largest gains in chest X-ray and non-contrast CT.